Safety of OnabotulinumtoxinA with Concomitant Antithrombotic Therapy in Patients with Muscle Spasticity: A Retrospective Pooled Analysis of Randomized Double-Blind Studies

BACKGROUND: OnabotulinumtoxinA is approved as a treatment across multiple indications. For the treatment of spasticity, onabotulinumtoxinA is injected directly into affected muscles. Intramuscular injections may result in local bleeding and related complications, especially in patients receiving ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimitrova, Rozalina, James, Lynn, Liu, Chengcheng, Orejudos, Amelia, Yushmanova, Irina, Brin, Mitchell F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125063/
https://www.ncbi.nlm.nih.gov/pubmed/32170665
http://dx.doi.org/10.1007/s40263-020-00709-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125063/
https://www.ncbi.nlm.nih.gov/pubmed/32170665
http://dx.doi.org/10.1007/s40263-020-00709-5

Ejemplares similares